US Broker Ratings

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Strong Growth and Strategic Partnerships Drive a 9.25% Potential Upside

For investors with an eye on the biotechnology sector, Halozyme Therapeutics, Inc. (NASDAQ: HALO) presents a compelling opportunity. This San Diego-based biopharmaceutical company, with a market..

Baxter International Inc. (BAX) Stock Analysis: Evaluating a 33.70% Potential Upside Amidst Financial Challenges

Baxter International Inc. (NYSE: BAX), a prominent player in the healthcare sector, is currently navigating a complex financial landscape that presents both challenges and opportunities for..

Ascendis Pharma A/S (ASND) Stock Analysis: A 26% Upside Potential Amid Robust Revenue Growth

Investors looking for opportunities in the healthcare sector might find Ascendis Pharma A/S (NASDAQ: ASND) an intriguing proposition. This Denmark-based biopharmaceutical company, with a market capitalization..

BrightSpring Health Services (BTSG) Stock Analysis: Exploring a 17.43% Potential Upside in Healthcare

BrightSpring Health Services, Inc. (BTSG) is capturing investor attention with its strong growth potential in the robust healthcare sector. As a key player in the Health..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Navigating a 21% Potential Upside Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is a prominent player in the biotechnology industry, specializing in RNA-targeted therapeutics and gene therapies. Despite its focus on pioneering treatments..

Repligen Corporation (RGEN) Investor Outlook: Unlocking a 30% Upside Potential in the Bioprocessing Market

Repligen Corporation (NASDAQ: RGEN) is a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. Headquartered in Waltham, Massachusetts, Repligen has..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a Challenging Market with a -25% Potential Downside

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare plans sector, operates with a mission to revolutionize the health insurance landscape through technology. As..

RadNet, Inc. (RDNT) Investor Outlook: A Promising Healthcare Contender with 4.92% Upside Potential

RadNet, Inc. (NASDAQ: RDNT), a leading provider of outpatient diagnostic imaging services, is making waves in the healthcare sector. With a market cap of $6.04 billion,..

Revvity, Inc. (RVTY) Stock Analysis: Exploring a 25% Potential Upside in Healthcare Diagnostics

Revvity, Inc. (RVTY), a prominent player in the healthcare sector specializing in diagnostics and research, offers an intriguing investment opportunity with a potential upside of 25.21%...

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Exploring a 13.89% Upside Potential Amidst Market Challenges

Bio-Rad Laboratories, Inc. (NYSE: BIO), a leading player in the healthcare sector, is at the forefront of the medical devices industry. With a market capitalization of..

Regencell Bioscience Holdings L (RGC) Stock Analysis: Navigating the Complexities of a High-Risk, High-Reward Proposition

Regencell Bioscience Holdings Limited (NASDAQ: RGC) is a unique player in the healthcare sector, particularly in the niche of drug manufacturers focusing on specialty and generic..

Masimo Corporation (MASI) Stock Analysis: Exploring a 30% Potential Upside in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI), a leading player in the healthcare sector, focuses on developing cutting-edge patient monitoring technologies and connectivity solutions. With a market capitalization of..

Guardant Health, Inc. (GH) Investor Outlook: Navigating a High-Growth, Volatile Landscape with 38.5% Revenue Surge

Guardant Health, Inc. (NASDAQ: GH) is quickly emerging as a formidable player in the healthcare diagnostics and research sector. Headquartered in Palo Alto, California, this precision..

Inspire Medical Systems, Inc. (INSP) Stock Analysis: Key Insights into Its 30.56% Potential Upside

Inspire Medical Systems, Inc. (NASDAQ: INSP) has emerged as a noteworthy player in the healthcare sector, particularly within the medical devices industry, thanks to its innovative..

CVS Health Corporation (CVS) Stock Analysis: Exploring a 15.86% Potential Upside and Strong Buy Ratings

CVS Health Corporation (NYSE: CVS) stands as a formidable player within the healthcare sector, particularly under the healthcare plans industry. Valued at approximately $100.27 billion, CVS..

Exelixis, Inc. (EXEL) Stock Analysis: Exploring a Promising 8.77% Upside in the Biotech Arena

Exelixis, Inc. (NASDAQ: EXEL) is making waves in the biotechnology sector, with its focus on pioneering treatments for challenging cancer types. Headquartered in Alameda, California, Exelixis..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring an 18.68% Potential Upside

Stevanato Group S.p.A. (NYSE: STVN), a key player in the medical instruments and supplies industry, presents an intriguing opportunity for investors looking to capitalize on the..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 48.4% Potential Upside in the Healthcare Sector

For investors keen on exploring opportunities in the healthcare sector, Grifols, S.A. (NASDAQ: GRFS) presents an intriguing prospect. With its headquarters in Barcelona, Spain, Grifols operates..

Lantheus Holdings (LNTH) Stock Analysis: Exploring a 60.98% Potential Upside

Lantheus Holdings, Inc. (NASDAQ: LNTH), a prominent player in the healthcare sector, has garnered significant attention from investors intrigued by its innovative diagnostic and therapeutic solutions...

HealthEquity, Inc. (HQY) Investor Outlook: Exploring a 29.96% Potential Upside with Strong Analyst Confidence

HealthEquity, Inc. (NASDAQ: HQY), a pivotal player in the healthcare sector, continues to capture investor attention with its promising growth trajectory and robust market presence. As..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds